2,295 Shares in Danaher Corporation $DHR Bought by Index Fund Advisors Inc.

Index Fund Advisors Inc. bought a new position in shares of Danaher Corporation (NYSE:DHR) during the second quarter, HoldingsChannel.com reports. The firm bought 2,295 shares of the conglomerate’s stock, valued at approximately $453,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. GHP Investment Advisors Inc. grew its stake in Danaher by 396.0% in the 1st quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 99 shares during the last quarter. Sierra Ocean LLC grew its holdings in shares of Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock worth $29,000 after buying an additional 76 shares in the last quarter. Red Tortoise LLC increased its stake in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after purchasing an additional 98 shares during the last quarter. Smallwood Wealth Investment Management LLC purchased a new position in shares of Danaher in the 1st quarter worth $31,000. Finally, Dunhill Financial LLC raised its stake in shares of Danaher by 68.4% in the 1st quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after acquiring an additional 67 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 11.10% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $202.53 on Monday. The firm has a market cap of $145.02 billion, a price-to-earnings ratio of 43.09, a PEG ratio of 2.88 and a beta of 0.77. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The business’s 50 day moving average is $200.66 and its two-hundred day moving average is $197.07. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business’s revenue was up 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Evercore ISI upped their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Rothschild Redb lowered Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Bank of America decreased their price target on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a report on Monday, September 22nd. Finally, Barclays reiterated an “overweight” rating and set a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Seventeen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $244.60.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.